Pricing and reimbursement frameworks in Central Eastern Europe: A decision tool to support choices

Katarzyna Kolasa, Zoltan Kalo, Edward Hornby

Research output: Contribution to journalArticle

6 Citations (Scopus)


Aim: Given limited financial resources in the Central Eastern European (CEE) region, challenges in obtaining access to innovative medical technologies are formidable. The objective of this research was to develop a decision tree that supports decision makers and drug manufacturers from CEE region in their search for optimal innovative pricing and reimbursement scheme (IPRSs). Methods: A systematic literature review was performed to search for published IPRSs, and then ten experts from the CEE region were interviewed to ascertain their opinions on these schemes. Results: In total, 33 articles representing 46 unique IPRSs were analyzed. Based on our literature review and subsequent expert input, key decision nodes and branches of the decision tree were developed. Conclusion: The results indicate that outcome-based schemes are better suited to deal with uncertainties surrounding cost effectiveness, while non-outcome-based schemes are more appropriate for pricing and budget impact challenges.

Original languageEnglish
Pages (from-to)145-155
Number of pages11
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Issue number1
Publication statusPublished - Feb 1 2015


  • Central Eastern European region
  • budget impact
  • cost effectiveness
  • innovative pricing and reimbursement schemes

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Pricing and reimbursement frameworks in Central Eastern Europe: A decision tool to support choices'. Together they form a unique fingerprint.

  • Cite this